000710 贝瑞基因
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-3.187-10.861-20.512-10.403-4.789
总资产报酬率 ROA (%)-2.223-7.508-14.372-7.411-3.453
投入资产回报率 ROIC (%)-2.606-8.911-16.689-8.587-3.994

边际利润分析
销售毛利率 (%)47.75346.86344.74542.71644.735
营业利润率 (%)-6.144-15.453-39.147-20.469-8.244
息税前利润/营业总收入 (%)-5.596-15.149-38.117-18.921-7.814
净利润/营业总收入 (%)-7.354-17.453-36.934-18.012-8.136

收益指标分析
经营活动净收益/利润总额(%)63.671-3.29311.46618.0699.740
价值变动净收益/利润总额(%)-15.8358.60013.63252.21438.604
营业外收支净额/利润总额(%)2.6832.4270.591-1.3177.868

偿债能力分析
流动比率 (X)2.4912.4371.9302.4502.472
速动比率 (X)2.1392.1071.6302.1232.167
资产负债率 (%)29.63028.07730.88327.28828.345
带息债务/全部投入资本 (%)11.90212.00217.89716.24815.759
股东权益/带息债务 (%)668.618700.282448.824506.053525.719
股东权益/负债合计 (%)233.229250.832220.188263.266249.427
利息保障倍数 (X)-7.805-22.006-30.192-14.764-6.891

营运能力分析
应收账款周转天数 (天)261.370250.439291.137283.014274.196
存货周转天数 (天)142.664133.282130.215106.76994.847